一项关于神经血管与年龄相关的黄斑退化症临床概况和视觉结果的前性观察研究
Ramamani Dalai1, Snigdha S Bedant2, Rajashree Rout3
1Ophthalmology, Fakir Mohan Medical College and Hospital, Balasore, IND.
Cureus
|February 22, 2024
概括
在患有新血管年龄相关黄斑退行症 (AMD) 的患者中,静脉内拉尼比祖马布显著改善了视力. 治疗决策应以光学连贯断层扫描 (OCT) 发现为指导,以获得最佳结果,重复注射.
科学领域:
- 眼科医生 眼科 眼科
- 视网膜疾病 视网膜疾病
- 医疗治疗 医疗治疗
背景情况:
- 神经血管与年龄相关的黄斑变性 (AMD) 是视力丧失的主要原因.
- 抗血管内皮生长因子 (抗VEGF) 疗法,特别是静脉内注射,是主要的治疗方式.
- 治疗的目的是保护视力,提高生活质量,防止黄斑损伤.
研究的目的:
- 为了评估不同类型的新血管AMD的临床过程.
- 评估新血管AMD患者对抗VEGF注射的治疗反应.
- 分析视觉结果并确定影响治疗疗效的因素.
主要方法:
- 东印度72名新血管性AMD患者的前性观察性研究.
- 临床数据收集包括最佳校正视敏度 (BCVA),眼底镜检查,光素血管学和OCT.
- 每月用三个月的静脉静脉拉尼比祖马布治疗,然后进行"需要时"的治疗方案.
主要成果:
- 从基线的Log MAR 1.061到研究后的0.787的平均BCVA显著改善 (p<0.05).
- 观察到52.78%的经典型,15.28%的最小经典型,31.94%的隐性AMD类型.
- 平均每眼5次拉尼比祖马布注射,68.05%的患者在第一次注射后初始视力改善.
结论:
- 内瑞拉尼比祖马布有效地改善了以前未接受过治疗的新血管AMD的视觉结果.
- 其他国家和地区的发现 (视网膜下液,PED,CME) 应指导反复注射抗VEGF.
- 基于OCT的量身定制的再治疗可以优化治疗结果并降低治疗负担.
更多相关视频
10:14Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
3.1K
05:14Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
1.1K
相关概念视频
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
